TREM2 and Alzheimer disease: These reports are consistent with a model wherein TREM2/TYROBP signaling is activated as a protective response against Aβ pathology; however, sustained TREM2/TYROBP activation may ultimately aggravate inflammatory and synapse-related pathologies, thereby driving AD progression.